Clinical Trial

A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
To evaluate the relationship between 18F-FSPG uptake in HCC lesions, ctDNA in blood and clinical response to Y90 radioembolization therapy in patients with hepatocellular carcinoma (HCC) by SOC imaging.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-08-07; most recent amendment 2026-06-09.
Status change: Not Yet Recruiting → Recruiting 2025-12-08
Trial Details
NCT Number NCT07116486
Lead Sponsor M.D. Anderson Cancer Center
Conditions Hepatocellular Carcinoma
Enrollment 60 participants
Start Date 2025-12-02
Primary Completion 2030-06-30 (estimated)
Study Completion 2032-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-10